Jens Tingleff

Publikation

Publikationer pr. år 2018 2018 2020 2021 2022 2023

• 9 Tidsskriftartikel
• 1 Bidrag til avis - Kommentar/debat
• 1 Andet bidrag

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2023

  COVID-19 mortality among selective serotonin reuptake inhibitor users - Results from a nationwide cohort

  Stauning, M. A., Gür, D. J., Torp-Pedersen, C. & Tingleff, J., 5 maj 2023, (E-pub ahead of print) I: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Serotonin Uptake Inhibitors 100%
  • Mortality 45%
  • Severe Acute Respiratory Syndrome 39%
  • Coronavirus 22%
  • Citalopram 15%
• 2022

  Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19

  Vasbinder, A., Anderson, E., Shadid, H., Berlin, H., Pan, M., Azam, T. U., Khaleel, I., Padalia, K., Meloche, C., O'Hayer, P., Michaud, E., Catalan, T., Feroze, R., Blakely, P., Launius, C., Huang, Y., Zhao, L., Ang, L., Mikhael, M., Mizokami-Stout, K., & 30 flerePennathur, S., Kretzler, M., Loosen, S. H., Chalkias, A., Tacke, F., Giamarellos-Bourboulis, E. J., Reiser, J., Eugen-Olsen, J., Feldman, E. L., Pop-Busui, R., Hayek, S. S., Hayek, S. S., Blakely, P., Berlin, H., Azam, T. U., Shadid, H., Pan, M., O'Hayer, P., Altintas, I., Stauning, M., Baltzer Houlind, M., Lindstrøm, M. B., Gamst-Jensen, H., Hartmann Rasmussen, L. J., Nehlin, J. O., Kallemose, T., Rasmussen, C., Andersen, O., Tingleff, J. & ISIC Study Group:, 1 mar. 2022, I: Diabetes Care. 45, 3, s. 692-700 9 s., dc212102.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Coronavirus 100%
  • Hyperglycemia 72%
  • Diabetes Mellitus 63%
  • Urokinase Plasminogen Activator Receptors 61%
  • Inflammation 46%

• Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19

  ISIC (International Study of Inflammation in COVID‐19) Group, Tingleff, J., Ahm Stauning, M., Houlind, M. B., Lindstrøm, M. B., Andersen, O., Gamst-Jensen, H., Rasmussen, L. J. H., Nehlin, J. & Kallemose, T., 20 sep. 2022, I: Journal of the American Heart Association. 11, 18, s. 1-15 15 s., e025198.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Venous Thromboembolism 77%
  • fibrin fragment D 67%
  • Decision Trees 8%
  • Forests 8%
  2 Citationer (Scopus)
• 2021

  Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department

  Ahm Stauning, M., Altintas, I., Kallemose, T., Eugen-Olsen, J., Lindstrøm, M. B., Rasmussen, L. J. H., Gamst-Jensen, H., Nehlin, J. O., Andersen, O. & Tingleff, J., 1 sep. 2021, I: The Journal of Emergency Medicine (Philadelphia). 61, 3, s. 298-313 16 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Patient Discharge 80%
  • Hospital Emergency Service 57%
  • Early Warning Score 28%
  • C-Reactive Protein 15%
  11 Citationer (Scopus)

• suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

  Altintas, I., Eugen-Olsen, J., Seppälä, S., Tingleff, J., Stauning, M. A., El Caidi, N. O., Elmajdoubi, S., Gamst-Jensen, H., Lindstrøm, M. B., Rasmussen, L. J. H., Kristiansen, K. T., Rasmussen, C., Nehlin, J. O., Kallemose, T., Hyppölä, H. & Andersen, O., 15 aug. 2021, I: Biomarker Insights. 16, s. 1-12 12 s., 11772719211034685.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Mechanical Ventilation 100%
  • Urokinase Plasminogen Activator Receptors 74%
  • Artificial Respiration 25%
  • SARS Virus 19%
  • Mortality 11%
  10 Citationer (Scopus)
• 2020

  Low levels of the prognostic biomarker supar are predictive of mild outcome in patients with symptoms of covid-19: a prospective cohort study

  Eugen-Olsen, J., Altintas, I., Tingleff, J., Ahm Stauning, M., Gamst-Jensen, H., Lindstrøm, M. B., Rasmussen, L. J. H., Kristiansen, K. T., Rasmussen, S. C., Nehlin, J., Kallemose, T. & Andersen, O., 2 jun. 2020, I: medRxiv : the preprint server for health sciences. s. 1-31 31 s., 20114678.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • SARS Virus 100%
  • Cohort Studies 92%
  • Biomarkers 88%
  • Prospective Studies 86%
  • Urokinase Plasminogen Activator Receptors 84%

• Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI

  International Study of Inflammation in COVID-19, nov. 2020, I: Journal of the American Society of Nephrology : JASN. 31, 11, s. 2725-2735 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Coronavirus 90%
  • Urokinase-Type Plasminogen Activator 81%
  • Dialysis 22%
  • Hospitalization 9%
  70 Citationer (Scopus)
• 2018

  Rarity of invasiveness in right-sided infective endocarditis

  Hussain, S. T., Shrestha, N. K., Witten, J., Gordon, S. M., Houghtaling, P. L., Tingleff, J., Navia, J. L., Blackstone, E. H. & Pettersson, G. B., 1 jan. 2018, I: Journal of Thoracic and Cardiovascular Surgery. 155, 1, s. 54-61

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Endocarditis 100%
  • Mitral Valve 34%
  • Aortic Valve 28%
  • Pulmonary Valve 7%
  • Host Microbial Interactions 7%
  24 Citationer (Scopus)

• suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

  Meyer, J., Alstrup, M., Rasmussen, L. J. H., Schultz, M., Ladelund, S., Haupt, T. H., Tingleff, J., Iversen, K. & Eugen-Olsen, J., 1 feb. 2018, I: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 26, 11

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Mortality 36%
  • Registries 17%
  • Computer Security 9%
  • Cohort Studies 9%
  8 Citationer (Scopus)